United States· US:71993-314_5c37b7e3-c3b4-67de-e063-6294a90a6680
RANITIDINE
A ranitidine product containing ranitidine hydrochloride, registered in United States by Atland Pharmaceuticals, LLC. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Ranitidine is registered in 9 of 19 countries.
Countries holding a registration under ATC A02BA02 (ranitidine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Ranitidine · ATC A02BA02
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ranitidine costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ranitidine · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- ES Spain$0.32
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- RANITIDINE HYDROCHLORIDE
- Manufacturer
- Atland Pharmaceuticals, LLC
- Country
- United States (US)
- ATC code
- A02BA02
- ATC class
- Ranitidine
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1171993-314-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
722 interactions on record for ranitidine.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ranitidine · interactions on record
722 records
- 14 severe
- 80 moderate
- 72 minor
- 552 info
Most severe, free to view
- LoperamideA07DA03severe
- AtazanavirJ05AE08severe
- RilpivirineJ05AG05severe
- DasatinibL01EA02severe
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ranitidine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHistac 150mg tabletsSun Pharma UK Ltd
- CanadaMAR-RANITIDINEMARCAN PHARMACEUTICALS INC
- SpainRANITIDINA ALTER 150 mg COMPRIMIDOS EFGLaboratorios Alter S.A.
- FinlandRantacidSchering Oy
- BelgiumAcidine 75 mgEG
- PolandRanigastZakłady Farmaceutyczne POLPHARMA S.A.
- GermanyRanitidin AlAliud Pharma Gmbh
- NorwayRanitidineSovereign
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Ranitidin Stada
- Bulgaria · Ранитидин Софарма
- Cyprus · Lumaren, Ranitidine Accord
- Germany · Ranitidin Al, Ranitidin Stada
- Spain · Ranitidina, Ranitidina Cinfa
- France · Ranitidine Eg, Ranitidine Zentiva
- United Kingdom (Northern Ireland) · Gavilast Heartburn And Indigestion, Indigestion Relief
- Greece · Aova, Baroxal
- Italy · Ranitidina Doc Generici, Ranitidina Eg
- Lithuania · Mediran, Ranitin
- Malta · Ranitidine Rosemont Pharmaceuticals
- Netherlands · Ranitidine Accord, Ranitidine Genrx
- Poland · Ranigast, Ranigast Max
- Portugal · Pep-Rani, Ranitidina Bluepharma
- Romania · Ranitidin Arena, Ranitidin Arena Group
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc5df048-9144-4733-89c0-e57878bbbfa6 GET /v1/drugs/fc5df048-9144-4733-89c0-e57878bbbfa6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "150",
"substance": "RANITIDINE HYDROCHLORIDE",
"productndc": "71993-314",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA211289",
"marketing_category": "ANDA"
}See everything about ranitidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.